Translational Development Acquisition (TDACU) Competitors $10.35 0.00 (0.00%) As of 06/20/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock TDACU vs. ASPCU, AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, ANSCU, and AITRUShould you be buying Translational Development Acquisition stock or one of its competitors? The main competitors of Translational Development Acquisition include A SPAC III Acquisition (ASPCU), AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), Agriculture & Natural Solutions Acquisition (ANSCU), and AI Transportation Acquisition (AITRU). These companies are all part of the "trading" industry. Translational Development Acquisition vs. Its Competitors A SPAC III Acquisition AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition AI Transportation Acquisition Translational Development Acquisition (NASDAQ:TDACU) and A SPAC III Acquisition (NASDAQ:ASPCU) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, community ranking, dividends, risk and profitability. Does the media favor TDACU or ASPCU? In the previous week, Translational Development Acquisition had 2 more articles in the media than A SPAC III Acquisition. MarketBeat recorded 2 mentions for Translational Development Acquisition and 0 mentions for A SPAC III Acquisition. A SPAC III Acquisition's average media sentiment score of 0.00 beat Translational Development Acquisition's score of -0.50 indicating that A SPAC III Acquisition is being referred to more favorably in the news media. Company Overall Sentiment Translational Development Acquisition Negative A SPAC III Acquisition Neutral Does the MarketBeat Community believe in TDACU or ASPCU? Translational Development Acquisition and A SPAC III Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformTranslational Development AcquisitionN/AN/AA SPAC III AcquisitionN/AN/A Which has stronger earnings and valuation, TDACU or ASPCU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTranslational Development Acquisition$5.64MN/AN/AN/AN/AA SPAC III AcquisitionN/AN/AN/AN/AN/A Is TDACU or ASPCU more profitable? Company Net Margins Return on Equity Return on Assets Translational Development AcquisitionN/A N/A N/A A SPAC III Acquisition N/A N/A N/A SummaryTranslational Development Acquisition beats A SPAC III Acquisition on 2 of the 3 factors compared between the two stocks. Get Translational Development Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for TDACU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TDACU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TDACU vs. The Competition Export to ExcelMetricTranslational Development AcquisitionInvestment Offices IndustryFinance SectorNASDAQ ExchangeMarket CapN/A$104.90M$11.76B$8.54BDividend YieldN/AN/A5.68%4.21%P/E RatioN/AN/A19.3719.17Price / SalesN/AN/A25.68109.16Price / CashN/AN/A20.7555.76Price / BookN/AN/A2.155.76Net IncomeN/AN/A$1.01B$248.88M7 Day PerformanceN/A0.89%0.20%2.13%1 Month Performance0.49%1.76%1.10%3.77%1 Year PerformanceN/A12.36%538.80%15.59% Translational Development Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TDACUTranslational Development AcquisitionN/A$10.35flatN/AN/A$0.00$5.64M0.00N/ALockup ExpirationASPCUA SPAC III AcquisitionN/A$10.35-1.3%N/AN/A$0.00N/A0.00N/APositive NewsAGBAWAGBA GroupN/A$0.09-17.8%N/A-73.1%$0.00$38.55M0.00152AGNCPAGNC InvestmentN/A$25.21+0.1%N/A+4.8%$0.00$584M0.0050Positive NewsAGNCOAGNC InvestmentN/A$25.64flatN/A+3.2%$0.00$584M0.0050Positive NewsAGNCNAGNC InvestmentN/A$25.80-0.1%N/A-0.3%$0.00$584M0.0050Positive NewsAGNCMAGNC InvestmentN/A$24.87-0.1%N/A-1.6%$0.00$584M0.0050AGNCLAGNC InvestmentN/A$25.24+0.0%N/A+4.1%$0.00$584M0.0050Positive NewsShort Interest ↓ANSCWAgriculture & Natural Solutions AcquisitionN/A$0.15flatN/AN/A$0.00N/A0.00N/APositive NewsGap DownANSCUAgriculture & Natural Solutions AcquisitionN/A$10.87+1.1%N/AN/A$0.00N/A0.00N/APositive NewsAITRUAI Transportation AcquisitionN/A$11.24flatN/AN/A$0.00N/A0.00N/A Related Companies and Tools Related Companies ASPCU Competitors AGBAW Competitors AGNCP Competitors AGNCO Competitors AGNCN Competitors AGNCM Competitors AGNCL Competitors ANSCW Competitors ANSCU Competitors AITRU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TDACU) was last updated on 6/22/2025 by MarketBeat.com Staff From Our PartnersThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored379 passengers walked away from thisForget OpenAI, ChatGPT, and the $2 trillion chip race… The real story is buried inside a new U.S. patent. E...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Translational Development Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Translational Development Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
